logo
I stopped drinking when I turned 50. Learning to travel sober was the hardest part.

I stopped drinking when I turned 50. Learning to travel sober was the hardest part.

Yahoo4 days ago

Drinking used to help Karthika Gupta connect with friends or loosen up in unfamiliar places.
Last year, when she turned 50, she decided to go alcohol free.
She often misses drinking while traveling, but appreciates waking up clear-headed.
I didn't start drinking until I was 25 — late by many standards — but once I did, alcohol quickly became both a social and professional currency.
As a management consultant, drinking was part of the job — be it wine during team dinners or Champagne toasts for successful product launches. It was also how I connected with friends, loosened up in unfamiliar places, and celebrated the highs of life on the road
Over the years, my passport filled up with stamps from trips where the days often followed the same pattern: explore by day, enjoy a drink or two at night. Warm sake in Japanese izakayas, a pint of Guinness in Dublin to celebrate St. Patrick's Day, and a cold beer after hiking in Patagonia weren't just drinks; they were part of how I celebrated traveling the world. I saw it as a way to immerse myself in local culture.
But something shifted the year I turned 50.
At first, it was a personal challenge where a "dry trip" extended a little longer to see how I felt. But the longer I stayed alcohol-free, the more curious I became about what else might shift.
Could I still feel joy at a celebratory dinner with friends without a glass of wine? Would I feel left out while traveling? Would people look at me differently, or worse, would I look at myself differently?
The first test came during a work trip to Switzerland. One night for dinner, we visited Fiescherblick, a boutique hotel in the Bernese Alps. I was surprised to find out they offered a non-alcoholic pairing menu.
That night, as the Eiger North Face glowed pink in the evening light, I sat down to one of the most memorable meals of my life. Each course arrived paired with a thoughtfully crafted elixir, like the rhubarb-kombucha aperitif that tingled on my tongue or a chilled berry and basil infusion with a root vegetable medley.
Each sip was as intentional and layered as any wine pairing I'd had in the past. I felt more aware and noticed how I slowed down during the meal, relishing every bite and sip. My body felt satiated but never dulled, and there was no fuzziness or brain fog — just the clarity of a crisp Alpine night and the satisfaction of enjoying every bite.
Since then, I've continued to travel alcohol-free. Some trips have been easy, but others have been really hard.
On an outdoor adventure-filled trip through Northern Ireland, known for its whiskey and beer, I felt discombobulated, like I was missing out on a big part of the local culture.
The hardest one was a two-week solo Antarctica cruise, during which the feeling of FOMO was very strong, especially when South America's best wines were served complimentary at dinner.
Almost 9 months have passed, and there are still moments when I'm handed a drink and feel a pang of awkwardness or worse, when someone asks, "Why not just have one?" with a puzzled smile. Social drinking is so normalized in travel that choosing to opt out can feel like rebellion.
But my choice has also been liberating. I've learned to start my days earlier and with more energy and to find other ways to connect with locals, like asking servers at restaurants about their favorite hangouts or listening to traditional Irish music at a local bar in Derry.
I no longer plan my evenings around drinks; instead, I look for live music, tea houses, night markets, or just quiet spaces to reflect.
Oddly enough, I feel more adventurous than I did before. Not drinking has pushed me to be more creative and intentional about how I seek joy. It's also helped me be more honest with myself and with others. I've realized how often I used alcohol as a shortcut to connecting with people when what I really needed was genuine curiosity and vulnerability.
I'm not here to make a case for sobriety or to say I'll never drink again. I'm simply in a season of exploring what it means to be fully awake to my experiences and how that changes the way I travel.
Going alcohol-free at 50 started as a personal experiment, but it's evolved into a new way to move through the world.
Read the original article on Business Insider

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories
Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories

CNN

time17 minutes ago

  • CNN

Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories

👋 Welcome to 5 Things PM! The US Food and Drug Administration is conducting the first comprehensive update and review of infant formula since 1998. 'We're going to make American infant formula the gold standard for the world,' Health and Human Services Secretary Robert F. Kennedy Jr. said. Here's what else you might have missed during your busy day: 1️⃣ 'We need to change': With President Donald Trump enacting tariffs on nearly every US import, American companies are scrambling to move their supply chains out of countries like Mexico and China. This small island in the Caribbean could be the answer. 2️⃣ Builders of peace: Congregation Bonai Shalom in Boulder, Colorado, welcomes both Jews and non-Jews to participate in all aspects of the community. An antisemitic attack that injured several members — including a Holocaust survivor — is testing their resilience. 3️⃣ Tracking measles: As cases rise to precipitously high levels in the US, there's a new tool to help measure the spread of the disease. Wastewater surveillance has the potential to identify possible cases days before an individual shows symptoms or seeks care. 4️⃣ Lunar lander: A Japanese company will try to touch down on the moon three months after an uncrewed American spacecraft did the same. Ispace executives said their slow and steady approach offers some long-term advantages. 5️⃣ Candid confession: Kylie Jenner detailed her breast augmentation on TikTok — down to the exact size. Her revelation chips away at a taboo. But is it a victory for transparency or a setback for beauty standards? GET '5 THINGS' IN YOUR INBOX CNN's 5 Things newsletter is your one-stop shop for the latest headlines and fascinating stories to start and end your busy day. Sign up here. ☔ Waterlogged: Flash flood emergencies were declared in Wichita and El Dorado, Kansas, after a month's worth of rain fell in one day. The heavy rain flooded roads and submerged cars. • Trump says Putin told him in phone call he will respond to Ukraine's weekend drone attacks• 2 Chinese researchers charged with smuggling biological pathogen to study at university lab• US Education Department threatens Columbia University's accreditation over campus antisemitism concerns 💸 That's how much House Republicans' sweeping tax and spending cuts package would add to the deficit over the next decade, according to a Congressional Budget Office analysis. 🪨 Preserving history: Stephen Townley Bassett is painstakingly recreating mysterious ancient rock art in South Africa before it's lost. His works are no ordinary replicas. I'm not going to be a part of Trump's lying. Pam Hemphill 💬 No thanks: Formerly known as 'MAGA Granny,' Hemphill is a convicted January 6 rioter who served two months in federal prison. Watch as she explains why she refused a pardon from President Trump. 🪖 Approximately how many Russian soldiers have been killed or injured in the war with Ukraine?A. 100,000B. 300,000C. 600,000D. 950,000⬇️ Scroll down for the answer. 🎾 C'est magnifique! Heavy underdog Lois Boisson continued her fairy tale run at the French Open tennis tournament by beating No. 6 seed Mirra Andreeva to advance to the semifinals. The hometown hero's next opponent? American Coco Gauff. 👋 We'll see you tomorrow.🧠 Quiz answer: D. Russia is nearing 1 million war casualties in Ukraine.📧 Check out all of CNN's newsletters. 5 Things PM is produced by CNN's Chris Good, Meghan Pryce, Kimberly Richardson and Morgan Severson.

Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories
Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories

CNN

time17 minutes ago

  • CNN

Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories

👋 Welcome to 5 Things PM! The US Food and Drug Administration is conducting the first comprehensive update and review of infant formula since 1998. 'We're going to make American infant formula the gold standard for the world,' Health and Human Services Secretary Robert F. Kennedy Jr. said. Here's what else you might have missed during your busy day: 1️⃣ 'We need to change': With President Donald Trump enacting tariffs on nearly every US import, American companies are scrambling to move their supply chains out of countries like Mexico and China. This small island in the Caribbean could be the answer. 2️⃣ Builders of peace: Congregation Bonai Shalom in Boulder, Colorado, welcomes both Jews and non-Jews to participate in all aspects of the community. An antisemitic attack that injured several members — including a Holocaust survivor — is testing their resilience. 3️⃣ Tracking measles: As cases rise to precipitously high levels in the US, there's a new tool to help measure the spread of the disease. Wastewater surveillance has the potential to identify possible cases days before an individual shows symptoms or seeks care. 4️⃣ Lunar lander: A Japanese company will try to touch down on the moon three months after an uncrewed American spacecraft did the same. Ispace executives said their slow and steady approach offers some long-term advantages. 5️⃣ Candid confession: Kylie Jenner detailed her breast augmentation on TikTok — down to the exact size. Her revelation chips away at a taboo. But is it a victory for transparency or a setback for beauty standards? GET '5 THINGS' IN YOUR INBOX CNN's 5 Things newsletter is your one-stop shop for the latest headlines and fascinating stories to start and end your busy day. Sign up here. ☔ Waterlogged: Flash flood emergencies were declared in Wichita and El Dorado, Kansas, after a month's worth of rain fell in one day. The heavy rain flooded roads and submerged cars. • Trump says Putin told him in phone call he will respond to Ukraine's weekend drone attacks• 2 Chinese researchers charged with smuggling biological pathogen to study at university lab• US Education Department threatens Columbia University's accreditation over campus antisemitism concerns 💸 That's how much House Republicans' sweeping tax and spending cuts package would add to the deficit over the next decade, according to a Congressional Budget Office analysis. 🪨 Preserving history: Stephen Townley Bassett is painstakingly recreating mysterious ancient rock art in South Africa before it's lost. His works are no ordinary replicas. I'm not going to be a part of Trump's lying. Pam Hemphill 💬 No thanks: Formerly known as 'MAGA Granny,' Hemphill is a convicted January 6 rioter who served two months in federal prison. Watch as she explains why she refused a pardon from President Trump. 🪖 Approximately how many Russian soldiers have been killed or injured in the war with Ukraine?A. 100,000B. 300,000C. 600,000D. 950,000⬇️ Scroll down for the answer. 🎾 C'est magnifique! Heavy underdog Lois Boisson continued her fairy tale run at the French Open tennis tournament by beating No. 6 seed Mirra Andreeva to advance to the semifinals. The hometown hero's next opponent? American Coco Gauff. 👋 We'll see you tomorrow.🧠 Quiz answer: D. Russia is nearing 1 million war casualties in Ukraine.📧 Check out all of CNN's newsletters. 5 Things PM is produced by CNN's Chris Good, Meghan Pryce, Kimberly Richardson and Morgan Severson.

Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032

Business Upturn

time2 hours ago

  • Business Upturn

Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032

New York, USA, June 04, 2025 (GLOBE NEWSWIRE) — Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight The AI in remote patient monitoring market is witnessing strong growth, driven by the increasing prevalence of chronic illnesses like cancer, cardiovascular conditions, and lifestyle-related disorders. This momentum is further boosted by a rise in product innovation, growing global investments in digital health infrastructure, and a heightened focus on proactive, data-centric healthcare approaches. These trends are anticipated to significantly accelerate the expansion of the AI-enabled RPM market throughout the forecast period of 2025 to 2032. DelveInsight's AI in Remote Patient Monitoring Market Insights report provides the current and forecast market analysis, individual leading AI in remote patient monitoring companies' market shares, challenges, AI in remote patient monitoring market drivers, barriers, trends, and key market AI in remote patient monitoring companies in the market. Key Takeaways from the AI in Remote Patient Monitoring Market Report As per DelveInsight estimates, North America is anticipated to dominate the global AI in remote patient monitoring market during the forecast period. In the product type segment of the AI in remote patient monitoring market, the devices category held the largest revenue share in 2024. Notable AI in remote patient monitoring companies such as Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., AliveCor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, and several others are currently operating in the AI in remote patient monitoring market. and several others are currently operating in the AI in remote patient monitoring market. In September 2024, iRhythm Technologies announced the Japanese regulatory approval of the zio® ECG monitoring system, the first product to deliver arrhythmia monitoring service utilizing artificial intelligence. announced the Japanese regulatory approval of the zio® ECG monitoring system, the first product to deliver arrhythmia monitoring service utilizing artificial intelligence. In April 2024, Royal Philips, a global leader in health technology, announced a strategic partnership to integrate smartQare's advanced solution, viQtor, with Philips' world-leading clinical patient monitoring platforms. This collaboration aims to enable the next generation of continuous patient monitoring both in and out of the hospital, starting in Europe. To read more about the latest highlights related to the AI in remote patient monitoring market, get a snapshot of the key highlights entailed in the Global AI in Remote Patient Monitoring Market Report AI in Remote Patient Monitoring Overview Artificial intelligence (AI) is revolutionizing remote patient monitoring (RPM) by enabling real-time, continuous health surveillance outside of traditional clinical settings. Through wearable devices and connected sensors, AI algorithms can analyze vital signs, detect anomalies, and predict potential health deterioration before symptoms become critical. This proactive approach allows for early interventions, reduces hospital readmissions, and improves chronic disease management, particularly for conditions like heart failure, diabetes, and COPD. By automating data analysis and triage, AI also significantly reduces the burden on healthcare professionals, allowing them to focus on patients who need urgent attention. Furthermore, AI-driven RPM fosters personalized care by learning from individual patient data over time. Machine learning models can adapt to each patient's unique health patterns, improving the accuracy of predictions and enabling tailored treatment plans. Natural language processing (NLP) tools can also interpret patient-reported symptoms via apps or voice interfaces, enriching the clinical picture. As AI technologies evolve, their integration into RPM systems is expected to enhance accessibility, especially in rural or underserved areas, bridging gaps in healthcare delivery while maintaining cost-efficiency and high-quality care. AI in Remote Patient Monitoring Market Insights North America is projected to lead the AI in remote patient monitoring market from 2025 to 2032. This dominance is largely driven by factors such as the growing prevalence of chronic diseases like cancer, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government initiatives. The region also benefits from significant investments in digital health and the extensive use of wearable and connected medical devices. The rising incidence of cancer in the U.S. and Canada is fueling the demand for continuous, home-based care solutions. This trend is accelerating the adoption of AI-driven remote patient monitoring, which enhances treatment management, symptom tracking, and patient outcomes outside traditional healthcare settings. Additionally, the increasing rates of cardiovascular diseases and related risk factors are heightening the need for ongoing and efficient monitoring solutions. AI-powered remote monitoring enables early detection, real-time intervention, and personalized care for heart patients, particularly in aging populations, thereby reducing complications and improving outcomes. Together, these factors create a favorable landscape for market expansion, solidifying North America's position as the leading region in the AI-based remote patient monitoring market throughout the forecast period. To know more about why North America is leading the market growth in the AI in remote patient monitoring market, get a snapshot of the AI in Remote Patient Monitoring Market Outlook AI in Remote Patient Monitoring Market Dynamics The AI in remote patient monitoring market is undergoing rapid transformation, driven by the convergence of advanced technologies, shifting healthcare models, and an increasing emphasis on personalized care. Artificial Intelligence is enhancing RPM systems by enabling real-time data analysis, predictive analytics, and automation, thereby helping providers manage chronic diseases, post-operative care, and elderly patients more effectively. AI algorithms can analyze vast volumes of patient data from wearable devices and home-based monitoring systems, identifying anomalies and alerting care teams before a crisis occurs. This proactive capability is fueling demand, particularly in value-based care models where preventing hospital readmissions is key. One of the primary drivers of this market is the global increase in chronic diseases and aging populations, which has led to an urgent need for continuous and cost-effective patient monitoring. AI-based RPM solutions not only reduce the burden on healthcare systems but also empower patients to manage their conditions better. Furthermore, the COVID-19 pandemic accelerated adoption, normalizing virtual care and remote diagnostics. This shift has continued post-pandemic, with healthcare providers and payers increasingly investing in AI-driven tools to support hybrid care models and decentralize service delivery. However, the market is not without its challenges. Data privacy, regulatory hurdles, and interoperability issues are key barriers to widespread adoption. The effectiveness of AI algorithms depends heavily on access to high-quality, diverse datasets, and data silos across healthcare institutions can limit this. Additionally, regulatory frameworks are still evolving to keep pace with AI's rapid advancement, and there's ongoing scrutiny about algorithmic bias and accountability. Addressing these challenges is crucial for building trust among clinicians and patients alike. On the competitive front, the market is witnessing intense innovation and strategic partnerships among tech firms, medtech companies, and healthcare providers. Startups are emerging with specialized AI capabilities in areas like arrhythmia detection, diabetic monitoring, and mental health assessment, while major players are integrating AI into their existing RPM platforms. Cloud infrastructure providers and AI-as-a-service vendors are also playing a key role in scaling solutions across geographies. Looking ahead, the AI in RPM market is expected to experience sustained growth, driven by advances in sensor technology, 5G connectivity, and federated learning models that allow privacy-preserving data sharing. As AI becomes more explainable and transparent, its integration into clinical workflows will deepen, making remote monitoring an integral part of mainstream healthcare delivery. Get a sneak peek at the AI in remote patient monitoring market dynamics @ AI in Remote Patient Monitoring Market Dynamic Analysis Report Metrics Details Coverage Global Study Period 2022–2032 AI in Remote Patient Monitoring Market CAGR ~27% AI in Remote Patient Monitoring Market Size by 2032 USD 13.1 Billion Key AI in Remote Patient Monitoring Companies Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., AliveCor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, among others AI in Remote Patient Monitoring Market Assessment AI in Remote Patient Monitoring Market Segmentation AI in Remote Patient Monitoring Market Segmentation By Product Type: Devices, Software, and Services AI in Remote Patient Monitoring Market Segmentation By Application: Cancer, Cardiovascular Disorder, Lifestyle Disorders, and Others AI in Remote Patient Monitoring Market Segmentation By End User: Hospitals and Clinics, Diagnostic Centers, and Homecare Setting AI in Remote Patient Monitoring Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the AI in remote patient monitoring market are set to emerge as the trendsetter explore @ AI in Remote Patient Monitoring Companies Table of Contents 1 AI in Remote Patient Monitoring Market Report Introduction 2 AI in Remote Patient Monitoring Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 AI in Remote Patient Monitoring Market Key Factors Analysis 6 AI in Remote Patient Monitoring Market Porter's Five Forces Analysis 7 AI in Remote Patient Monitoring Market Layout 8 AI in Remote Patient Monitoring Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the AI in remote patient monitoring market by 2032? Click to get a snapshot of the AI in Remote Patient Monitoring Market Trends Related Reports Patient Monitoring Devices Market Patient Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key patient monitoring devices companies, including Medtronic plc, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, among others. Artificial Intelligence in Drug Commercialization Market Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others. Artificial Intelligence in Precision Medicine Market Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Envisionit Deep AI (Pty) Ltd., Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others. Artificial Intelligence In Drug Discovery Market Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others. Artificial Intelligence in Medical Imaging Market Artificial Intelligence in Medical Imaging Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in medical imaging companies, including Microsoft, Siemens Healthineers, GE Healthcare, NVIDIA Corporation, Philips Healthcare, Arterys, Butterfly Network, Enlitic, HeartFlow, Digital Diagnostics, among others. DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion. Other Business Pharmaceutical Consulting Services Healthcare Conference Coverage Pipeline Assessment Healthcare Licensing Services Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store